BIT's 7th Annual Symposium of Drug Delivery Systems (SDDS-2017)
★ Scientific Programme

BIT's 7th Annual International Symposium of

Drug Delivery Systems-2017

Time: July 12-14, 2017
Venue: Prague, Czech Republic

 

Scientific Program
Keynote Forum Track-1 Track-2 Track-3 Track-4
Track-5 Track-6 Track-7 -

 

 

 

 Track 3: Targeted Drug Delivery
 

Session 3-1: New Oral, Transmucoadhesive, Buccal, Inhalation & Respiratory Drug Delivery

Time: 13:30-17:10, July 12, 2017 (Wednesday)

Place: Prague D, 2nd Floor, Vienna House Diplomat Prague

Chair

Dr. Igor Gonda, President & CEO, Aradigm Corporation, USA

Co-chair

Mr. Sarath Chandar, E VP Technology & Licensing, SPI Pharma, USA

13:30-13:55  

Title: Inhalation & Respiratory Drug Delivery
Dr. Igor Gonda,
President & CEO, Aradigm Corporation, USA

13:55-14:20  

Title: Oral Film Technology Evolution, Challenges and Therapeutic Benefits
Dr. Rodolphe Obeid,
Director, Research and Development; Director, Process Development and Manufacturing Scale-Up, IntelGenx Corp., Canada

14:20-14:45

Title: Innovation in Rapid onset Oral Delivery
Dr. John McCarty,
President, IntraTAB Labs Inc., USA

14:45-15:10

Title: XStraw® - Medication Really Easy
Dr. Elke Sternberger-Rutzel,
Scientific Director, DS Technology GmbH, Germany

15:10-15:30 Coffee Break
15:30-15:55 Title: Inhaled Vaccine
Dr. Orest Lastow,
CEO, Iconovo AB, Sweden
 
 15:55-16:20 Title: An Effective Alternative to Pharmaceutical Syrups & Suspensions for Children
Mr. Sarath Chandar,
E VP Technology & Licensing, SPI Pharma, USA
16:20-16:45 Title: Effective Sublingual Drug Delivery of Flumazenil Versus Intravenous Injection for Reversing the Residual Sedative Effect of Hypnotic Drugs
Dr. Shimon Amselem,
Chief Scientist, ADAMA, Israel
16:45-17:10

Title: Mucoadhesive Buccal Delivery Systemfor Nicotine HCl Using Low Molecular Weight Chitosan and Carbopol 971P
Dr. Shereen M. Assaf,
Associate Professor, Jordan University of Science and Technology, Jordan

  

Session 3-2: New Ocular, Nasal, Pulmonary, Brain, Inhalation & Respiratory Drug Delivery

Time: 10:00-12:05, July 13, 2017 (Thursday)

Place: Prague B, 2nd Floor, Vienna House Diplomat Prague

Chair Dr. Thomas Birngruber, Head, Biomedical Engineering and Monitoring Research Group, JOANNEUM RESEARCH, Austria (to be confirmed)
10:00-10:25  

Title: Monitoring of Transport across the Intact BBB with Cerebral Open Flow Microperfusion (cOFM)
Dr. Thomas Birngruber, Head, Biomedical Engineering and Monitoring Research Group, JOANNEUM RESEARCH, Austria

10:25-10:50

Title: Transporters in the Blood Brain Barrier-regulation of Brain Drug Exposure
Dr. Peter Krajc,
Chief Scientific Officer, SOLVO Biotechnology, Hungary

10:50-11:15

Title: Niacinamide is a Potent Uptake Enhancer in Nasal Drug Delivery
Mr. Hubert Pellikaan,
Director, Nextstep Pharma BV, The Netherlands

11:15-11:40 Title: Predictable and Precise Intra-arterial Opening of the Blood Brain Barrier using Real-time MRI Guidance
Dr. Miroslaw Janowski,
Associate Professor, Johns Hopkins University, USA
11:40012:05 Title: EyeSol: A Water-free Platform for Ocular Drug Delivery
Dr. Hartmut Voss,
Chief Business Officer, Novaliq, Germany

 

Session 3-3: Targeting Cancer Drug Delivery

Time: 13:30-16:20, July 14, 2017 (Friday)

Place: Prague A, 2nd Floor, Vienna House Diplomat Prague

Chair Dr. Iwao Ojima, Distinguished Professor, Stony Brook University – State University of New York; Director , Institute of Chemical Biology & Drug Discovery, USA
13:30-13:55  

Keynote Speech

 

Title: Next-generation Taxane Anticancer Agents and their Tumor-targeted Delivery
Dr. Iwao Ojima,
Distinguished Professor, Stony Brook University – State University of New York; Director , Institute of Chemical Biology & Drug Discovery, USA

13:55-14:20

Keynote Speech

Title: Current Advances and Challenges into Magnetic Iron Oxide Nanoparticles: A Biomedical Perspective
Dr. Ani Binti Idris,
Professor, Universiti Teknologi Malaysia, Malaysia

14:20-14:45

Title: CAR T Cell Manufacturing and Delivery for Cancer Treatment
Dr. Mateusz Poltorak,
Senior Scientist, Juno Therapeutics GmbH, Germany

14:45-15:10

 

 

Title: Adenovirus Dodecahedron as a Nanoplatform for Cancer Therapy
Dr. Ewa Szolajska,
Group Leader, Institute of Biochemistry and Biophysics, Polish Academy of Sciences, Poland

 

15:10-15:30 Coffee Break
15:30-15:55

Title: Intra-thecal Drug Delivery for Treatment of Chronic Non-cancer Pain
Dr. Maged Hamza,
Director, Neuromodulation Program, VCU Spine Center, USA

15:55-16:20

Title: Nanotechology and Targeting Cancer cells via Drug Delivery
Dr. Jim Phillips,
Chief Executive Officer, Midatech Pharma PLC, UK

 

 

Time arrangement in final program is subject to change without notice.

News Updates

· Early Bird Registration!
· Speaking Proposals Accepted Now!
· Submit the Abstract Right Now!

Hosting Organization

whtslogo.JPG
World High Technology Society (WHTS)

Operating Organization

BIT Group Global Ltd.

Official Travel Agency

BIT World Travel Service, Inc.

Media Partners

BIT's Upcoming Events


Contact Us

Add: East Area, F11, Building 1, Dalian Ascendas IT Park, 1 Hui Xian Yuan, Dalian Hi-tech Industrial Zone, LN 116025, China
Tel: 0086-411-84799609, Fax: 0086-411-84796897
Copyright © 2016-2017 BIT Group Global Ltd.